Schizophrenia Research
Volume 41, Issue 3 , Pages 405-415 , 14 February 2000

Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?

  • Vibeke Sørensen Catts

      Affiliations

    • Schizophrenia Research Unit, South Western Sydney Area Health Service, Don Everett Building, Liverpool Hospital, PO Box 103, Liverpool, NSW 2170, Australia
    • ,
  • Stanley Victor Catts

      Affiliations

    • School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-2-9828-6182; fax: +61-2-9828-6181

Received 9 December 1998 ,Accepted 16 April 1999.

References 

  1. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch. Gen. Psychiatry. 1996;53:425–436
  2. Allebeck P, Wistedt B. Mortality in schizophrenia. Arch. Gen. Psychiatry. 1986;43:650–653
  3. Andreasen NC. The role of the thalamus in schizophrenia. Can. J. Psychiatry. 1997;42:27–33
  4. Armstrong E, Curtis M, Buxhoeveden DP, Fregoe C, Zilles K, Casanova M, et al. Cortical gyrification in the rhesus monkey: a test of the mechanical folding hypothesis. Cereb. Cortex. 1991;1:426–432
  5. Armstrong E, Schleicher A, Omran H, Curtis M, Zilles K. The ontogeny of human gyrification. Cereb. Cortex. 1995;5:56–63
  6. Baldwin JA. Schizophrenia and physical disease. Psychol. Med. 1979;9:611–618
  7. Baldwin JA. Schizophrenia and physical disease. In:  Hemmings G editors. The Biochemistry of Schizophrenia and Addiction. Lancaster: MTP Press; 1980;p. 297–317
  8. Benes FM, Davidson J, Bird ED. Quantitative cytoarhitectural studies of the cerebral cortex of schizophrenics. Arch. Gen. Psychiatry. 1986;43:31–35
  9. Burkhalter A, Bernardo KL, Charles V. Development of local circuits in human visual cortex. J. Neurosci. 1993;13:1916–1931
  10. Catts SV, Ward PB, Lloyd A, Huang XF, Dixon G, Chahl L, et al. Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia. Aust. New Zealand J. Psychiatry. 1997;31:17–26
  11. de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry. 1995;152:453–455
  12. Dupont A, Jensen OM, Strömgren E, Jablensky A. Incidence of cancer in patients diagnosed as schizophrenic in Denmark. In:  ten Horn GHMM,  Giel R,  Gulbinat WH,  Henderson JH editor. Psychiatric Case Registers in Public Health. Amsterdam: Elsevier; 1986;p. 229–239
  13. Falkai P, Bogerts B. The neuropathology of schizophrenia. In:  Hirsch SR,  Weinberger DR editor. Schizophrenia. Cambridge: Blackwell Science; 1995;(Chapter 15)
  14. Ferrer I, Soriano E, Del Rio JA, Alcántara A, Auladell C. Cell death and removal in the cerebral cortex during development. Prog. Neurobiol. (Oxf.). 1992;39:1–43
  15. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA. 1997;94:587–592
  16. Friauf E, McConnell SK, Shatz CJ. Functional synaptic circuits in the subplate during fetal and early postnatal development of cat visual cortex. J. Neurosci. 1990;10:2601–2613
  17. Greenlund LJS, Korsmeyer SJ, Johnson EM. Role of BCL-2 in the survival and function of developing and mature sympathetic neurons. Neuron. 1995;15:649–661
  18. Gulbinat W, Dupont A, Jablensky A, Jensen OM, Marsella A, Nakane Y, et al. Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries. Br. J. Psychiatry. 1992;161(Suppl. 18):75–85
  19. Harrison PJ. Schizophrenia: a disorder of neurodevelopment?. Curr. Opin. Neurobiol. 1997;7:285–289
  20. Harvey I, Ron MA, Du Boulay G, Wicks D, Lewis SW, Murray RM. Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol. Med. 1993;23:591–604
  21. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry. 1986;143:993–997
  22. Jacks T, Weinberg RA. Cell-cycle control and its watchman. Nature. 1996;381:643–644
  23. Jánicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 1998;273:9357–9360
  24. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr. Bull. 1996;22:413–430
  25. Jones EG. Cortical development and thalamic pathology in schizophrenia. Schizophr. Bull. 1997;23:483–501
  26. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 1972;26:239–257
  27. Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, et al. Transgenic mice with p53-responsive lacZ:p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 1997;16:1391–1400
  28. Kulynych JJ, Luevano LF, Jones DW, Weinberger DR. Cortical abnormality in schizophrenia: an in vivo application of the gyrification index. Biol. Psychiatry. 1997;41:995–999
  29. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323–331
  30. Liddle P. Brain imaging. In:  Hirsch SR,  Weinberger DR editor. Schizophrenia. Cambridge: Blackwell Science; 1995;(Chapter 22)
  31. McDonald JW, Behrens MI, Chung C, Bhattacharyya T, Choi DW. Susceptibility to apoptosis is enhanced in immature cortical neurons. Brain Res. 1997;759:228–232
  32. McGrath JJ, van Os J, Hoyos C, Jones PB, Harvey I, Murray RM. Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables. Schizophr. Res. 1995;18:9–20
  33. McGrath JJ, Murray R. Riskfactors for schizophrenia: from conception to birth. In:  Hirsch SR,  Weinberger DR editor. Schizophrenia. Cambridge: Blackwell Science; 1995;(Chapter 12)
  34. McNeil TF. Obstetric factors and perinatal injuries. In:  Tsuang MT,  Simpson JC editor. Nosology, Epidemiology and Genetics.  Nasralla HA editors. Handbook of Schizophrenia. vol. 3:Amsterdam: Elsevier; 1988;p. 319–345
  35. Majdan M, Lachance C, Gloster A, Aloyz R, Zeindler C, Bamji S, et al. Transgenic mice expressing the intracellular domain of the p75 neurotrophin receptor undergo neuronal apoptosis. J. Neurosci. 1997;17:6988–6998
  36. Miyashita T, Reed JC. Tumour suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293–299
  37. Mortensen PB. Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr. Scand. 1987;75:585–590
  38. Mortensen PB. The incidence of cancer in schizophrenic patients. J. Epidemiol. Community Health. 1989;43:43–47
  39. Mortensen PB. Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr. Scand. 1992;85:390–393
  40. Mortensen PB. The occurrence of cancer in first admitted schizophrenic patients. Schizophr. Res. 1994;12:185–194
  41. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br. J. Psychiatry. 1993;163:183–189
  42. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama KI, Nakayama K, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 1995;267:1506–1509
  43. Mrzljak L, Uylings HBM, Kostovic I, Van Eden CG. Prenatal development of neurons in the human prefrontal cortex. J. Comp. Neurol. 1988;271:355–386
  44. Nakane Y, Ohta Y. The example of linkage with a cancer register. In:  ten Horn GHMM,  Giel R,  Gulbinat WH,  Henderson JH editor. Psychiatric Case Registers in Public Health. Amsterdam: Elsevier; 1986;p. 240–245
  45. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 1990;47:1023–1028
  46. Parsadanian AS, Cheng Y, Keller-Peck CR, Holtzman DM, Snider WD. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J. Neurosci. 1998;18:1009–1019
  47. Portin P, Alanen YO. A critical review of genetic studies of schizophrenia. II. Molecular genetic studies. Acta Psychatr. Scand. 1997;95:73–80
  48. Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397–400
  49. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. Programmed cell death and the control of cell survival: lessons from the nervous system. Science. 1993;262:695–700
  50. Raz S, Raz N. Structural brain abnormalities in the major psychoses, a quantitative review of the evidence from computerized imaging. Psychol. Bull. 1990;108:93–108
  51. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA. 1994;91:7525–7529
  52. Shatz CJ, Chun JJM, Luskin MB. The role of the subplate in the development of the mammalian telecephalon. In:  Peters A,  Jones EG editor. Development and Maturation of Cerebral Cortex. Cerebral Cortex. vol. 7:New York: Plenum Press; 1988;p. 35–58
  53. Silos-Santiago I, Greenlund LJS, Johnson EM, Snider WD. Molecular genetics of neuronal survival. Curr. Opin. Neurobiol. 1995;5:42–49
  54. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456–1462
  55. Tuck SP, Crawford L. Characterisation of the human p53 gene promoter. Mol. Cell. Biol. 1989;9:2163–2172
  56. Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr. Bull. 1994;20:441–451
  57. Watson CG, Gasser B, Schaefer A, Buranen C, Wold J. Separation of brain damaged from psychiatric patients with ability and personality measures. Clin. Psychol. 1981;37:347–353
  58. Weinberger D. Schizophrenia: from neuropathology to neurodevelopment. Lancet. 1995;346:552–557
  59. Welker W. Why does cerebral cortex fissure and fold? A review of determinants of gyri and sulci. In:  Jones EG,  Peters A editor. Cerebral Cortex. vol. 8B:New York: Plenum Press; 1990;p. 3–139
  60. Wu X, Bayle JH, Olson D, Levine AJ. The p53–mdm-2 autoregulatory feedback loop. Genes Dev. 1993;7:1126–1132
  61. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555–556
  62. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A. Wide-spread cerebral grey matter volume deficits in schizophrenia. Arch. Gen. Psychiatry. 1992;49:195–205

PII: S0920-9964(99)00077-8

Schizophrenia Research
Volume 41, Issue 3 , Pages 405-415 , 14 February 2000

Article Tools

* Image Usage & Resolution